What is Sionna Therapeutics, Inc. Common Stock's Market Cap?

Sionna Therapeutics, Inc. Common Stock's Market Cap is $330.1M, based on as-reported figures from SEC (XBRL) filings.

What is Sionna Therapeutics, Inc. Common Stock's Enterprise Value?

Sionna Therapeutics, Inc. Common Stock's Enterprise Value is $266.7M, based on as-reported figures from SEC (XBRL) filings.

What is Sionna Therapeutics, Inc. Common Stock's EV / EBITDA?

Sionna Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Sionna Therapeutics, Inc. Common Stock's Net Income (TTM)?

Sionna Therapeutics, Inc. Common Stock's Net Income (TTM) is -$97.4M, based on as-reported figures from SEC (XBRL) filings.

What is Sionna Therapeutics, Inc. Common Stock's EBITDA?

Sionna Therapeutics, Inc. Common Stock's EBITDA is -$108.8M, based on as-reported figures from SEC (XBRL) filings.

What is Sionna Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Sionna Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.15, based on as-reported figures from SEC (XBRL) filings.

What is Sionna Therapeutics, Inc. Common Stock's Net Debt?

Sionna Therapeutics, Inc. Common Stock's Net Debt is -$63.3M, based on as-reported figures from SEC (XBRL) filings.

Sionna Therapeutics, Inc. Common Stock (SION) Financial Statements

Sionna Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG016X2DCF7

XNAS · usd

7.30▲ 0.12 (1.67%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close7.18

Day's Range6.89 – 7.56

52-Week Range4.01 – 54.97

Volume881.9K

Avg Volume3.3M

Share Statistics

Shares Outstanding

Employees59

ExchangeXNAS

Listed2025-02-07

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Sionna Therapeutics, Inc. Common Stock (SION)

What is Sionna Therapeutics, Inc. Common Stock's Market Cap?: Sionna Therapeutics, Inc. Common Stock's Market Cap is $330.1M, based on as-reported figures from SEC (XBRL) filings.
What is Sionna Therapeutics, Inc. Common Stock's Enterprise Value?: Sionna Therapeutics, Inc. Common Stock's Enterprise Value is $266.7M, based on as-reported figures from SEC (XBRL) filings.
What is Sionna Therapeutics, Inc. Common Stock's EV / EBITDA?: Sionna Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Sionna Therapeutics, Inc. Common Stock's Net Income (TTM)?: Sionna Therapeutics, Inc. Common Stock's Net Income (TTM) is -$97.4M, based on as-reported figures from SEC (XBRL) filings.
What is Sionna Therapeutics, Inc. Common Stock's EBITDA?: Sionna Therapeutics, Inc. Common Stock's EBITDA is -$108.8M, based on as-reported figures from SEC (XBRL) filings.
What is Sionna Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Sionna Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.15, based on as-reported figures from SEC (XBRL) filings.
What is Sionna Therapeutics, Inc. Common Stock's Net Debt?: Sionna Therapeutics, Inc. Common Stock's Net Debt is -$63.3M, based on as-reported figures from SEC (XBRL) filings.